Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using ¹⁸F-fluorodeoxiglucose Positron Emission Tomography (¹⁸F-FDG-PET)

By Miyata Hiroshi   Yamasaki Makoto   Takahashi Tsuyoshi   Murakami Kohei   Tanaka Koji   Yukinori Kurokawa   Nakajima Kiyokazu   Takiguchi Shuji   Morii Eiichi   Hatazawa Jun   Mori Masaki   Doki Yuichiro  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Usefulness of ¹⁸F‐Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero‐Pancreatic Neuroendocrine Neoplasms

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 186-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary tuberculosis with false-positive 18F-fluorodeoxyglucose positron emission tomography mimicking recurrent lung cancer: A case report

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 159-161

Spandidos Publications

Access to resources Recommend Favorite

Incidental Breast Lesions Identified by 18F-Fluorodeoxyglucose-Positron Emission Tomography

By Chung Alice  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2119-2125

Springer Publishing Company

Access to resources Recommend Favorite

Measurement of clinical and subclinical tumour response using [ 18 F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations - reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-d-glucose uptake at PET

By Young H.   Baum R.   Cremerius U.   Herholz K.   Hoekstra O.   Lammertsma A.A.   Pruim J.   Price P.  

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1773-1782

Elsevier

Access to resources Recommend Favorite